Across TCGA pan-cancer cohorts, RPL9P14 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of RPL9P14’s most consistent transcriptional readouts.
The strongest signal is observed in thyroid carcinoma (THCA), where RPL9P14 RNA is repressed in tumor relative to normal tissue. In most cancer types RPL9P14 is over-expressed in tumor, although a few such as THCA and KICH show the opposite, repressed pattern.
THCA, KICH, and UCEC are the cancer types where RPL9P14 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL9P14 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.